Cargando…
Cyclosporine, prednisone, and high-dose immunoglobulin treatment of angioimmunoblastic T-cell lymphoma refractory to prior CHOP or CHOP-like regimen
Angioimmunoblastic T-cell lymphoma (AITL) is a rare, distinct subtype of peripheral T-cell lymphoma, possessing an aggressive course and poor prognosis with no standard therapy. Twelve patients who have failed at least two initial CHOP or CHOP-like regimens were enrolled in this study and treated wi...
Autores principales: | Chen, Xing-Gui, Huang, He, Tian, Ying, Guo, Cheng-Cheng, Liang, Chao-Yong, Gong, Yao-Ling, Zou, Ben-Yan, Cai, Rui-Qing, Lin, Tong-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sun Yat-sen University Cancer Center
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012273/ https://www.ncbi.nlm.nih.gov/pubmed/21959050 http://dx.doi.org/10.5732/cjc.011.10071 |
Ejemplares similares
-
Severe Pulmonary Adverse Effects in Lymphoma Patients Treated with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) Regimen Plus Rituximab
por: Lim, Kyu-Hyoung, et al.
Publicado: (2010) -
Rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in diffuse large B-cell lymphoma
por: Candelaria, Myrna, et al.
Publicado: (2021) -
Recombinant human endostatin in combination with CHOP regimen for peripheral T cell lymphoma
por: Zhang, Qunling, et al.
Publicado: (2016) -
Outcome of R-CHOP or CHOP Regimen for Germinal Center and Nongerminal Center Subtypes of Diffuse Large B-Cell Lymphoma of Chinese Patients
por: Huang, Ying, et al.
Publicado: (2012) -
Outcomes of GDPT (gemcitabine, cisplatin, prednisone, thalidomide)
versus CHOP in newly diagnosed peripheral T-cell lymphoma
patients
por: Sun, Yuanyuan, et al.
Publicado: (2020)